FORT SHERIDAN ADVISORS LLC – Lineage Cell Therapeutics, Inc. Transaction History
FORT SHERIDAN ADVISORS LLC portfolio value:
$95,000
portfolio value
FORT SHERIDAN ADVISORS LLC quarter portfolio value change:
-28.48%
quarter
Lineage Cell Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +6.33% | 5K shares | -30K | $1.13 | 83.93K |
| Q2 2022 | share | Increase | +3.95% | 3K shares | 8K | $1.58 | 78.93K |
| Q1 2022 | share | Increase | +43.45% | 23K shares | -13K | $1.54 | 75.93K |
| Q4 2021 | share | Increase | +10.43% | 5K shares | 9K | $2.5 | 52.93K |
| Q3 2021 | share | 0.00% | 0 shares | -16K | $2.52 | 47.93K | |
| Q2 2021 | share | Increase | +6.68% | 3K shares | 31K | $2.85 | 47.93K |
| Q1 2021 | share | Increase | 0.00% | 44.93K shares | 106K | $2.35 | 44.93K |